Table 2.
HCoVs |
Clinical Symptoms |
Incubation Period |
References |
---|---|---|---|
HKU1 |
Fever, Cough, Respiratory Tract Illness (RTI), Sneezing, Dyspnea, Pneumonia |
2–4 days |
|
229E |
Fever, Chills, Cough, Acute Rhinorrhea, Malaise, Nasal Congestion and Discharge, Headache, Throat Sore |
2–5 days |
|
OC43 |
Fever, Cold, Cough, Sputum, Dyspnea, Headache, Nasal Congestion and Discharge, Sneezing, Throat Sore |
2–5 days |
|
NL63 |
Fever, Cold, Cough, Respiratory Distress, Wheeze, Rales, Rhinorrhea, Tachypnea, Hypoxia |
2–4 days |
|
MERS‐CoV |
Fever, Cough, Cold, Shortness of Breath, Gastrointestinal Symptoms, Sore Throat, Arthralgia, Diarrhea and Vomiting, Pneumonia, Acute Renal Impairment, Multiple Organ Failures, Rapid Kidney Failure |
2–13 days |
|
SARS‐CoV |
Fever, Cough, Cold, Rigor, Shortness Of Breath, Gastrointestinal Symptoms, Myalgias, Headache, Malaise, Dyspnea, Respiratory Distress, Diarrhea, Pneumonia |
2–11 days |
|
SARS‐CoV‐2 (COVID‐19) |
Fever, Coughing, Cold, Sore Throat, Nasal Congestion and Rhinorrhea, Diarrhea, Asymptomatic, Organ Function Damage, Acute Kidney And Cardiac Infection, Liver Dysfunction, Pneumothorax |
2–14 days but in some cases extended to 24 days |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.